A process for optimizing the recoverability of lyophilized microspheres for emboli and chitosan microspheres to which a drug-containing carrier is bound are disclosed. Specifically, a process for optimizing the recoverability, which includes adding trehalose as a lyophilization protectant prior to a lyophilization process for stable storage of the microspheres, and vortexing the lyophilized microspheres in order to rehydrate the microspheres, is provided. Also, microspheres capable of precisely controlling the release of the drug since the quantity of a drug released from the chitosan microspheres having a drug-containing nano-carrier bound thereto is adjusted according to the drug/chitosan ratio, and a method of preparing the same are provided. The optimization process can be useful in maintaining the physical properties, shapes, and the drug release level of the microspheres for emboli even after lyophilization of the microspheres. The chitosan microspheres having the drug-containing nano-carrier bound thereto can be useful in stably causing emboli in blood vessels, and precisely adjusting the release of the drug, and thus can be used in anticancer treatment.
本发明公开了一种优化用于栓塞的冻干微球和结合了含药载体的
壳聚糖微球的可回收性的工艺。具体地说,本发明提供了一种优化可回收性的工艺,其中包括在冻干工艺前添加曲哈洛糖作为冻干保护剂,以稳定储存微球,并对冻干微球进行涡旋以重新
水化微球。此外,还提供了能够精确控制药物释放的微球,因为从结合了含药纳米载体的
壳聚糖微球中释放的药物量可根据药物/
壳聚糖的比例进行调整,还提供了制备这种微球的方法。该优化过程有助于保持微球的物理性质、形状和药物释放
水平,即使在微球冻干后仍可用于栓塞。结合了含药纳米载体的
壳聚糖微球可以稳定地在血管中形成栓子,并精确地调节药物的释放,因此可用于抗癌治疗。